Survival of Staphylococcus aureus on sampling swabs stored at different temperatures.

bacterial storage conditions community sampling of S. aureus determining bacterial concentration microbial viability storing bacterial samples survival of bacteria on swabs swab samples

Journal

Journal of applied microbiology
ISSN: 1365-2672
Titre abrégé: J Appl Microbiol
Pays: England
ID NLM: 9706280

Informations de publication

Date de publication:
Sep 2021
Historique:
revised: 26 01 2021
received: 04 12 2020
accepted: 01 02 2021
pubmed: 6 2 2021
medline: 16 10 2021
entrez: 5 2 2021
Statut: ppublish

Résumé

To understand the impact of storage temperature on recovery of Staphylococcus aureus on sampling swabs. Staphylococcus aureus is a common cause of skin and soft tissue infections, but also causes a variety of life-threatening diseases. With a large pool of asymptomatic carriers and transmission that can occur even through indirect contact, mitigation efforts have had limited success. Swab sampling, followed by culturing, is a cornerstone of epidemiological studies, however, S. aureus viability on swabs stored at different temperatures has not been characterized. We determined survival rates on swabs stored at five different temperatures. Samples stored at -70°C had no decay over time while samples stored at higher temperatures showed an exponential decay in viability. Mortality rates were greatest for swabs stored at 37°C. Survival at intermediate temperatures (-20 to 20·5°C) did not differ significantly, however, we observed more variation at higher temperatures. To maximize recovery of S. aureus cells, samples should be stored at -70°C or processed for culturing without delay. Epidemiological studies of bacterial diseases are typically limited to determination of pathogen presence/absence, yet quantitative assessments of pathogen load and genetic diversity can provide insights into disease progression and severity, likelihood of transmission and adaptive evolutionary potential. For studies of S. aureus where time or access to a microbiology laboratory may delay culturing, deep freezing or timely culturing will maximize the degree to which sampling results reflect source status.

Identifiants

pubmed: 33544965
doi: 10.1111/jam.15023
pmc: PMC8339145
mid: NIHMS1679822
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1030-1038

Subventions

Organisme : NIAID NIH HHS
ID : R15 AI156771
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD012388
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54MD012388
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : R15AI156771
Organisme : NIMHD NIH HHS
ID : U54MD012388
Pays : United States

Informations de copyright

© 2021 The Authors. Journal of Applied Microbiology published by John Wiley & Sons Ltd on behalf of Society for Applied Microbiology.

Références

J Bacteriol. 1998 Apr;180(7):1750-8
pubmed: 9537371
mBio. 2012 Feb 21;3(1):
pubmed: 22354957
J Clin Microbiol. 2000 Feb;38(2):724-6
pubmed: 10655374
Microb Drug Resist. 2011 Sep;17(3):457-61
pubmed: 21612512
Eur J Clin Microbiol Infect Dis. 2011 Aug;30(8):943-9
pubmed: 21298460
J Med Microbiol. 1997 Mar;46(3):222-32
pubmed: 9126823
Lancet Infect Dis. 2005 May;5(5):275-86
pubmed: 15854883
Front Microbiol. 2018 May 03;9:866
pubmed: 29774015
PLoS One. 2010 Apr 06;5(4):e10040
pubmed: 20386721
J Clin Microbiol. 2008 May;46(5):1655-8
pubmed: 18353935
J Appl Microbiol. 2017 Jun;122(6):1603-1614
pubmed: 28375570
J Clin Microbiol. 2012 Jul;50(7):2466-8
pubmed: 22535993
J Hosp Infect. 2006 Jul;63(3):289-97
pubmed: 16650507
Bacteriol Rev. 1963 Mar;27:56-71
pubmed: 14000926
Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8821-6
pubmed: 11447287
BMC Genomics. 2019 Mar 20;20(1):229
pubmed: 30894139
J Food Prot. 2009 May;72(5):1121-38
pubmed: 19517746
J Food Prot. 2020 May 1;83(5):844-848
pubmed: 31928413
J Clin Microbiol. 1999 Oct;37(10):3133-40
pubmed: 10488166
Bacteriol Rev. 1966 Sep;30(3):674-7
pubmed: 5917341
MMWR Morb Mortal Wkly Rep. 2019 Mar 08;68(9):214-219
pubmed: 30845118
J Clin Microbiol. 2007 Apr;45(4):1278-83
pubmed: 17267627
J Appl Bacteriol. 1990 Mar;68(3):271-8
pubmed: 2111304
PLoS One. 2014 Oct 29;9(10):e111627
pubmed: 25353631
Diagn Microbiol Infect Dis. 2006 Sep;56(1):19-24
pubmed: 16822635
PLoS One. 2012;7(1):e29031
pubmed: 22291884
Nat Rev Microbiol. 2009 Sep;7(9):629-41
pubmed: 19680247
JMIR Res Protoc. 2019 Sep 27;8(9):e14853
pubmed: 31573953
Clin Infect Dis. 2016 Dec 1;63(11):1431-1438
pubmed: 27516381
BMC Infect Dis. 2006 Aug 16;6:130
pubmed: 16914034
Cryobiology. 1982 Apr;19(2):211-4
pubmed: 7083887
J Hosp Infect. 2000 Jul;45(3):231-4
pubmed: 10896803
Lancet Infect Dis. 2005 Dec;5(12):751-62
pubmed: 16310147
Sci Adv. 2015 Jun 05;1(5):e1400216
pubmed: 26601194
Clin Microbiol Rev. 1997 Jul;10(3):505-20
pubmed: 9227864

Auteurs

D Panisello Yagüe (D)

Pathogen & Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA.

J Mihaljevic (J)

School of Informatics, Computing, and Cyber Systems, Northern Arizona University, Flagstaff, AZ, USA.

M Mbegbu (M)

Pathogen & Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA.

C V Wood (CV)

Pathogen & Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA.

C Hepp (C)

School of Informatics, Computing, and Cyber Systems, Northern Arizona University, Flagstaff, AZ, USA.

S Kyman (S)

Pathogen & Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA.

H Hornstra (H)

Pathogen & Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA.

R Trotter (R)

Department of Anthropology, Northern Arizona University, Flagstaff, AZ, USA.

E Cope (E)

Pathogen & Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA.

T Pearson (T)

Pathogen & Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH